A carregar...
Metformin is a potent inhibitor of endometrial cancer cell proliferation – implications for a novel treatment strategy
OBJECTIVES: Obesity and diabetes are strong risk factors that drive the development of type I endometrial cancers. Recent epidemiological evidence suggests that metformin may lower cancer risk and reduce rates of cancer deaths among diabetic patients. In order to better understand metformin's a...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2789879/ https://ncbi.nlm.nih.gov/pubmed/19822355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2009.09.024 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|